Waning and boosting of antibody Fc-effector functions upon SARS-CoV-2 vaccination

Waning and boosting of antibody Fc-effector functions upon SARS-CoV-2 vaccination

Abstract Since the emergence of SARS-CoV-2, vaccines targeting COVID-19 have been developed with unprecedented speed and efficiency. CoronaVac, utilising an inactivated form of the COVID-19 virus and the mRNA26 based Pfizer/BNT162b2 vaccines are widely distributed. Beyond the ability of vaccines to...

Full description

Bibliographic Details
Main Authors: X. Tong, R. P. McNamara, M. J. Avendaño, E. F. Serrano, T. García-Salum, C. Pardo-Roa, H. L. Bertera, T. M. Chicz, J. Levican, E. Poblete, E. Salinas, A. Muñoz, A. Riquelme, G. Alter, R. A. Medina
Format: Article
Language:English
Published: Nature Portfolio 2023-07-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-023-39189-8

Internet

https://doi.org/10.1038/s41467-023-39189-8

Similar Items